Ethics

Satel on Neuromarketing

By Adam Kolber

Sally Satel writes in Forbes about neuromarketing hype, particularly of the EEG variety.  Here's how she concludes:

Having raised an impressive $9 million, the least one can safely say about EmSense is that it surely knows how to market itself. But whether EmSense, or other neuromarketers for that matter, can deliver on their high-tech promises remains to be seen.

You can read the full article here.

Full post as published by Neuroethics and Law on December 14, 2009 (boomark / email).